These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 23104576)

  • 1. Effectiveness of preoperative screening for sickle cell disease in a population with a newborn screening program: a cohort study.
    O'Leary JD; Odame I; Pehora C; Chakraborty P; Crawford MW
    Can J Anaesth; 2013 Jan; 60(1):54-9. PubMed ID: 23104576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative screening for sickle cell disease in children: clinical implications.
    Crawford MW; Galton S; Abdelhaleem M
    Can J Anaesth; 2005 Dec; 52(10):1058-63. PubMed ID: 16326676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
    Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening program for hemoglobinopathies in Rio de Janeiro, Brazil.
    Lobo CL; Ballas SK; Domingos AC; Moura PG; do Nascimento EM; Cardoso GP; de Carvalho SM
    Pediatr Blood Cancer; 2014 Jan; 61(1):34-9. PubMed ID: 24038856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates.
    Al Hosani H; Salah M; Osman HM; Farag HM; Anvery SM
    East Mediterr Health J; 2005 May; 11(3):300-7. PubMed ID: 16602448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states.
    Kavanagh PL; Wang CJ; Therrell BL; Sprinz PG; Bauchner H
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):15-22. PubMed ID: 18200513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
    Alvarez OA; Hustace T; Voltaire M; Mantero A; Liberus U; Saint Fleur R
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening shows a high incidence of sickle cell anemia in Central India.
    Jain DL; Sarathi V; Upadhye D; Gulhane R; Nadkarni AH; Ghosh K; Colah RB
    Hemoglobin; 2012; 36(4):316-22. PubMed ID: 22712682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recognition of children with sickle cell disease in The Netherlands].
    Heijboer H; Van den Tweel XW; Fijnvandraat K; Peters M
    Ned Tijdschr Geneeskd; 2007 Nov; 151(45):2498-501. PubMed ID: 18062592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening.
    Peters M; Fijnvandraat K; van den Tweel XW; Garre FG; Giordano PC; van Wouwe JP; Pereira RR; Verkerk PH
    Arch Dis Child; 2010 Oct; 95(10):822-5. PubMed ID: 20576657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for abnormal hemoglobins: who, when, and how.
    McCurdy PR
    Prim Care; 1980 Sep; 7(3):451-60. PubMed ID: 6905205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening for sickle cell disease: effect on mortality.
    Vichinsky E; Hurst D; Earles A; Kleman K; Lubin B
    Pediatrics; 1988 Jun; 81(6):749-55. PubMed ID: 3368274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First case of Hb Fontainebleau with sickle haemoglobin and other non-deletional α gene variants identified in neonates during newborn screening for sickle cell disorders.
    Upadhye DS; Jain D; Nair SB; Nadkarni AH; Ghosh K; Colah RB
    J Clin Pathol; 2012 Jul; 65(7):654-9. PubMed ID: 22461654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening for sickle cell and other hemoglobinopathies: a Canadian pilot study.
    Yorke D; Mitchell J; Clow C; Nuguid E; Cadogan R; Sinclair D; Luscombe S; Rozen R; Meredith P; Esseltine D
    Clin Invest Med; 1992 Aug; 15(4):376-83. PubMed ID: 1516295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of the polymerase chain reaction to the diagnosis of sickle cell anemia in Venezuela].
    Martínez J; Blanco Z; Hakshaw P; Moreno N
    Sangre (Barc); 1998 Feb; 43(1):63-6. PubMed ID: 9577183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia.
    Paulukonis ST; Snyder A; Smeltzer MP; Sutaria AN; Hurden I; Latta K; Chennuri S; Vichinsky E; Reeves SL
    J Pediatr Hematol Oncol; 2023 May; 45(4):174-180. PubMed ID: 37083273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased prevalence of false positive hemoglobinopathy newborn screening in premature infants.
    Hustace T; Fleisher JM; Sanchez Varela AM; Podda A; Alvarez O
    Pediatr Blood Cancer; 2011 Dec; 57(6):1039-43. PubMed ID: 21584936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn screening for sickle cell disease in a Nigerian hospital.
    Odunvbun ME; Okolo AA; Rahimy CM
    Public Health; 2008 Oct; 122(10):1111-6. PubMed ID: 18486954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Campaign to control genetic blood diseases in Bahrain.
    Al Arrayed S
    Community Genet; 2005; 8(1):52-5. PubMed ID: 15767757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease.
    Moat SJ; Rees D; King L; Ifederu A; Harvey K; Hall K; Lloyd G; Morrell C; Hillier S
    Clin Chem; 2014 Feb; 60(2):373-80. PubMed ID: 24158758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.